Trials / Conditions / Asperger's Disorder

Asperger's Disorder

16 registered clinical trials studyying Asperger's Disorder.

Status	Trial	Sponsor	Phase
Unknown	An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum NCT02199925	Isaac Melamed	Phase 4
Completed	GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs NCT01808066	CogCubed, Corp	N/A
Terminated	Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Di NCT01592773	Forest Laboratories	Phase 2
Completed	Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Development NCT01592747	Forest Laboratories	Phase 2
Completed	An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive D NCT01592786	Forest Laboratories	Phase 2
Completed	Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder NCT01631851	Yale University	N/A
Completed	D-Cycloserine and Social Skills Training in Autism Spectrum Disorders NCT01086475	Indiana University	Phase 3
Completed	Cognitive Neuroscience of Autism Spectrum Disorders NCT01031407	National Institute of Mental Health (NIMH)	—
Terminated	Memantine in Adult Autism Spectrum Disorder NCT01078844	Johns Hopkins University	N/A
Completed	Adolescent Social Skills Training Program NCT01031823	Milton S. Hershey Medical Center	N/A
Completed	The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder NCT00808782	Bayside Health	N/A
Completed	Atomoxetine, Placebo and Parent Management Training in Autism NCT00844753	University of Rochester	Phase 4
Withdrawn	Mercury Chelation to Treat Autism NCT00376194	National Institute of Mental Health (NIMH)	Phase 2
Completed	An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders NCT00308074	Cambridge Health Alliance	Phase 2
Completed	A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. NCT00198055	Indiana University School of Medicine	Phase 2
Completed	Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study NCT00352196	Augusta University	Phase 4